The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Intravenous Fluid Transfer Drug Devices Market Projected To Expand During 2026–2030?
The intravenous fluid transfer drug devices market has experienced robust growth recently. It is projected to expand from $7.85 billion in 2025 to $8.35 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. Historically, this growth can be attributed to factors such as the continued reliance on conventional IV sets, the rise in hospital and clinical procedures, the restricted availability of smart infusion devices, increasing understanding of IV therapy advantages, and the adoption of PVC infusion bags.
The intravenous fluid transfer drug devices market is anticipated to experience substantial growth in the coming years. It is projected to reach $10.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This expansion during the forecast period can be attributed to several factors, including ongoing technological advancements in smart infusion pumps, a growing need for pre-filled and multi-chamber infusion bags, increased applications within oncology and neurology, the expansion of home healthcare and ambulatory infusion services, and more stringent regulatory and quality standards. Key trends expected over the forecast period include the increasing adoption of smart infusion devices and pumps, greater utilization of pre-filled and multi-chamber infusion bags, a rising demand for needleless connectors and safety IV sets, the broader application of IV therapy in chronic and critical care treatments, and a heightened emphasis on sterility, accuracy, and flow control.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp
Which Growth Drivers Are Expected To Support The Intravenous Fluid Transfer Drug Devices Market Forward?
An increasing rate of hospitalizations is projected to stimulate the expansion of the intravenous fluid transfer drug device market moving forward. This rise in hospitalization rates is attributed to an aging population, the prevalence of chronic illnesses, advancements in diagnostics, and improved access to healthcare, alongside lifestyle-related diseases and progress in medical technology. Fluid transfer systems are essential for the precise and controlled delivery of fluids and medications directly into the bloodstream of patients admitted to hospitals. For instance, according to GOV.UK, a US-based government agency, by March 2023, COVID-19 hospital admissions in England had slightly increased to 10.62 per 100,000 in 2023, while ICU/HDU admissions remained low at 0.28 per 100,000. Most regions experienced minor increases, with rates largely stable across various age groups. Therefore, an escalating hospitalization rate is expected to propel the growth of the intravenous fluid transfer drug device market.
What Are The Major Segment Categories Within The Intravenous Fluid Transfer Drug Devices Market?
The intravenous fluid transfer drug devices market covered in this report is segmented –
1) By Type: Infusion Bags, Infusion Devices, Other Types
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors
Subsegments:
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices
What Trends Are Affecting The Growth Of The Intravenous Fluid Transfer Drug Devices Market?
Major companies operating within the intravenous fluid transfer drug device market are creating modular and extensive infusion systems equipped with functionalities like auto-identification. These systems are designed to improve precision, bolster patient safety, and simplify the administration of fluids and medications. Auto-identification in infusion systems works by automatically confirming and matching medications to the appropriate patient, utilizing either barcode scanning or RFID technology. For instance, in July 2023, Becton, Dickinson, and Company, a US-based medical device firm, received FDA 510(k) clearance for its updated BD Alaris Infusion System. The BD Alaris Infusion System features upgraded hardware for its Point-of-Care Unit (PCU), which encompasses large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Furthermore, it introduces an advanced software version that offers enhanced cybersecurity and interoperability, allowing for smooth integration with commonly used electronic medical record (EMR) systems, thereby supporting smart and interconnected healthcare.
Which Organizations Are Involved In The Intravenous Fluid Transfer Drug Devices Market?
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG
Access The Complete Intravenous Fluid Transfer Drug Devices Market Report:
Which Region Stands As The Largest Contributor To The Intravenous Fluid Transfer Drug Devices Market?
North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Intravenous Fluid Transfer Drug Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company
Neurovascular Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report
Peripheral Iv Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report
Central Venous Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model